In short. Stem cell, exosome, growth factor and own-blood language, each read for what it actually names and what it leaves out.
Key points
- A description of contents and a statement of authorisation are different kinds of sentence.
- The first can be written about anything.
- The second can only be written where somebody has assessed the product, and it is the one that determines whether the claim being made is permitted at all.
Claims in this category are built from a small vocabulary, and each term names something real while being used to imply something that has not been shown. Reading each one for what it actually names is the whole of the exercise.
Stem cell language
The words describe a cell type. They are used to suggest that the cells will survive, take on a function and rebuild tissue, and survival is exactly what the evidence does not support. Where a product is described by the cells it contains rather than by what it is authorised for, the description has taken the place of the fact that decides most of the question.
Exosome language
Exosomes are material released by cells, and a product described as containing them has been described by its contents. Products of this kind are generally not approved as cosmetic treatments, and regulators in several markets have issued warnings about advertising them for any condition. A precise description of what exosomes are is not a regulatory fact about the product, and the two are easy to confuse on a well-written page.
What a product is made of is not what it is authorised for
A description of contents and a statement of authorisation are different kinds of sentence. The first can be written about anything. The second can only be written where somebody has assessed the product, and it is the one that determines whether the claim being made is permitted at all.
Growth factor language
Growth factors measured in laboratory work establish that the substances are present and released under those conditions. Whether they reach living tissue in a concentration that matters, remain long enough to act and produce a change a person can see is a chain of steps the laboratory work does not follow. The finding is real and it is about a dish.
Own-blood language
It establishes where the material came from, which is accurate and is used to imply a safety and a naturalness that the source alone does not provide. Removing the risk of donor transmission does not remove the risk of what happens during preparation, and the preparation is where the main risk of a point-of-care biologic sits.
Photographs and testimonials
Paired photographs are the most persuasive and least controlled evidence in the field: lighting, angle, expression and camera position all change between two images, and a difference produced by any of them looks the same as one produced by treatment. A person’s account of their own experience is genuine, cannot be generalised, and cannot be separated from everything else that changed over the same months.
Three questions that sort a regenerative claim
- Does this sentence name what the product contains, or what it is authorised for?
- Does it describe an intention, a mechanism, or an outcome that somebody measured?
- If the mechanism is right, what would a person notice, and has anybody shown that?
Most claims here resolve into one of two groups: an accurate description of contents, or an outcome promise attached to it. Only one of them tells you anything about what you would be buying.
Frequently asked questions
What does stem cell language actually name?
It names a cell type, and it is used to imply that the cells will survive and rebuild tissue. Whether they do is the question the word is doing the work of answering. Where a product is described by its cells and not by its authorisation, the description has replaced the fact that matters.
What should I make of exosome language?
Exosomes are material released by cells, and describing a product as containing them says what it is made of rather than what it does. Products of this kind are generally not approved as cosmetic treatments, and warnings have been issued about advertising them for any condition.
How should I read growth factor and own-blood language?
Both describe a mechanism or a source rather than a result. Growth factors measured in a laboratory establish that something is released under those conditions. Own blood establishes where the material came from. Neither is a statement about what happens in a face.
Risks & Limitations
- The word regenerative describes a marketing position rather than an approved class, and no authority approves a material as regenerative.
- Cell and exosome products are generally not approved as cosmetic treatments, and warnings have been issued about advertising them as treatments.
- Most injected cells do not survive in useful numbers, which is the step that a claim of tissue rebuilding depends on.
- An absence of reported harm in an unapproved product is an absence of reporting rather than a finding of safety.
- A point-of-care preparation carries a risk of infection introduced during preparation, because blood handled outside a controlled laboratory is a medium in which bacteria grow.
When to Seek Care
- Redness, warmth, swelling or pain that is increasing rather than settling after a procedure.
- Discharge from an injection site, or a fever — seek prompt clinical assessment.
- Any new and persistent symptom after a procedure, or a change in the treated area that concerns you.
- Contact the service that performed the treatment, or the hospital’s outpatient channels, rather than relying on a website.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — warnings and guidance on unapproved cell and exosome products
- European Medicines Agency (EMA) and national regulators — advanced therapy classification and guidance
- National Medical Products Administration (NMPA, China) — approved biological products and their indications
- World Health Organization (WHO) — guidance on cell and tissue-based therapies and their oversight
- Cochrane Library — systematic reviews of cell-based and platelet treatments for skin indications
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.